secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001193125-24-235949
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq panel grants Bellevue Life Sciences continued listing; must meet public holders rule by Feb 2025
--------------------------------------------------------------------------------

- Received Nasdaq notice Feb 2024 for failing minimum 300 public holders; plan approved with extension to Aug 13, 2024.
- Did not regain compliance by Aug 13; requested hearing which stayed suspension.
- Hearing held Oct 1, 2024; Panel granted continued listing on Oct 4, 2024.
- Must demonstrate compliance with Listing Rule 5505 by Feb 17, 2025, with prompt notification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524235949/0001193125-24-235949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312524235949/d846929d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-235949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer